An FDA approval has officially lifted the curtain on a blockbuster market showdown between Novartis and Eli Lilly in early breast cancer. The FDA has greenlighted Novartis’ Kisqali, used in ...

The Palm Beach County Sheriff’s Department has a potential suspect in custody, a man who was identified by numerous news outlets as Ryan ... and his property in Florida, and I am glad he is ...

The suspect in the second assassination attempt on former President Trump laughed and smiled ahead of his first court appearance in Florida on Monday. Ryan Wesley Routh, wearing jail scrubs and ...

Meta, the parent company of Facebook and Instagram, announced Monday that it has banned Russian state media broadcaster RT and other Kremlin-controlled networks, alleging the outlets have engaged ...

Meta said it has banned Kremlin-run state media outlet Russia Today as well as other networks controlled by the regime of President Vladimir Putin due to alleged “foreign interference activity.” ...

Florida, with police later apprehending a suspect who was identified by multiple news outlets as Ryan Wesley Routh. Former President Donald Trump is safe after gunshots were reported near him ...

Sheriff Carmine Marceno fired back late Monday against his political opponent, who claims Marceno is the subject of an FBI investigation into reports of money laundering and acceptance of ...

Hard Rock Bet has returned to Florida, with a full-scale state-wide launch taking place on Dec. 5, 2023. Here's a timeline of Florida's sports betting journey to date: Sept. 3, 2024: 10 people are ...

Thursday, nonprofit news outlet Florida Trident broke the news that Marceno had allegedly laundered money through former honorary deputy Ken Romano, and was under investigation by the FBI.

Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for ...

Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for the treatment of adults and ...

Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese ...